REG - IP Group PLC - Further re Scrip Dividend

IPAnnouncement

14/09/2022 16:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220914:nRSN4936Za&default-theme=true

RNS Number : 4936Z  IP Group PLC  14 September 2022

 FOR RELEASE ON  14 September 2022

 

IP Group plc - Further re Scrip Dividend

 

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"),
which develops world-changing science and technology businesses across life
sciences, technology and cleantech, announces that, further to the
announcements dated 03 August 2022, 18 August 2022 and 13 September 2022 in
connection with the Interim Scrip Dividend, the Group has received valid
elections from shareholders resulting in a requirement to issue 154,718 new
ordinary shares of 2p each ("New Shares").

 

An application has been made for the New Shares to be issued in connection
with the Scrip Dividend to be admitted to the premium segment of the Official
List of the Financial Conduct Authority and to trading on the main market for
listed securities of the London Stock Exchange respectively.

 

Admission of the New Shares is expected to be effective on 20 September 2022.
Following admission and in accordance with the Disclosure Guidance and
Transparency Rules of the Financial Conduct Authority, the Group will have
1,063,188,005 Ordinary Shares in issue and 28,607,622 Ordinary Shares in
Treasury.

 

The total number of Ordinary Shares with voting rights following the issue of
the New Shares will be 1,034,580,383 Ordinary Shares. This figure may be used
by shareholders in the Group as the denominator for the calculation by which
they will determine if they are required to notify their interest in, or a
change to their interest in, the share capital of the Group under the
Disclosure Guidance and Transparency Rules of the Financial Conduct Authority.

 

For more information, please contact:

 

 IP Group plc                                              www.ipgroupplc.com (http://www.ipgroupplc.com)
 David Baynes, Chief Financial and Operating Officer       +44 (0) 20 7444 0050

Liz Vaughan-Adams, Communications
+44 (0) 20 7444 0062/+44 (0) 7967 312125

 

Notes for editors

 

About IP Group

 

IP Group develops world-changing science and technology businesses across life
sciences, technology and cleantech (through Kiko Ventures). The Group has a
strong track record of success, having been the founder investor in a number
of high-profile companies including Oxford Nanopore Technologies plc, and has
one of the most exciting portfolios of high-growth businesses in Europe. The
Group also owns Parkwalk, the UK's largest growth EIS fund manager which backs
world-changing technologies emerging from the UK's leading universities and
research institutions. IP Group is listed on the Main Market of the London
Stock Exchange under the code IPO.

 

For more information, please visit our website at www.ipgroupplc.com
(http://www.ipgroupplc.com/) .

 

ENDS

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  FURGPUGWBUPPGAC